within Pharmacolibrary.Drugs.S_SensoryOrgans.S01A_Antiinfectives.S01AE05_Levofloxacin;

model Levofloxacin_1
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C(
    weight = 70,
    F = 1,
    Cl = 2.361111111111111e-06,
    adminDuration = 600,
    adminMass = 500 / 1000000,
    adminCount = 1,
    Vd = 0.074,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    Vdp = 0.047,
    k12 = 3.5277777777777775e-06,
    k21 = 3.5277777777777775e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Levofloxacin_1</td></tr><tr><td>ATC code:</td><td>S01AE05_1</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>500</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>74</td><td>L</td></tr>
    <tr><td>clearance:</td><td>8.5</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Levofloxacin is a broad-spectrum fluoroquinolone antibiotic used for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, and skin infections. It is an approved medication and is widely used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Setiawan, E, et al., &amp; Roberts, JA (2022). Population pharmacokinetics and dose optimization of intravenous levofloxacin in hospitalized adult patients. <i>Scientific reports</i> 12(1) 8930–None. DOI:<a href=\"https://doi.org/10.1038/s41598-022-12627-1\">10.1038/s41598-022-12627-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35624222/\">https://pubmed.ncbi.nlm.nih.gov/35624222</a></p></li><li><p>Zhang, Y, et al., &amp; Sun, L (2014). Population pharmacokinetics of intravenous levofloxacin 500 mg/day dosage in infected patients. <i>Die Pharmazie</i> 69(7) 553–557. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25073403/\">https://pubmed.ncbi.nlm.nih.gov/25073403</a></p></li><li><p>Jaruratanasirikul, S, et al., &amp; Samaeng, M (2018). Population Pharmacokinetics and Pharmacodynamics Modeling of Oral Levofloxacin. <i>Journal of the Medical Association of Thailand = Chotmaihet thangphaet</i> 99(8) 886–892. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29947489/\">https://pubmed.ncbi.nlm.nih.gov/29947489</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.S.S01AE05_1 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Levofloxacin_1;
